USE OF ANTI-FAM19A1 ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES

The present disclosure relates to a method of treating a disease or disorder associated with an abnormality in CNS function. Also provided is a method for diagnosing and/or identifying a subject having an abnormality in CNS function. FAM19A1 antagonists that can be used with the present disclosures are also provided..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 03. Apr. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

KIM BONGCHEOL [VerfasserIn]
KIM DONG SIK [VerfasserIn]
KWON SOON-GU [VerfasserIn]
HA NUI [VerfasserIn]
SEONG JAE YOUNG [VerfasserIn]
HWANG JONG IK [VerfasserIn]
YONG HYO JUNG [VerfasserIn]
CHO EUN BEE [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A01K: Animal husbandry; aviculture; apiculture; piscicult (...)
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che
G01N: Investigating or analysing materials by determining (...)
hor
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-04-03, Last update posted on www.tib.eu: 2024-04-16, Last updated: 2024-04-19

Patentnummer:

EP4114855

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000177903